Gastric Adenocarcinoma
Showing NaN - NaN of 20
Gastric Adenocarcinoma, Carcinomatosis Trial in Houston (Paclitaxel, Dexamethasone, Diphenhydramine)
Not yet recruiting
- Gastric Adenocarcinoma
- Carcinomatosis
- Paclitaxel
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Aug 7, 2023
Metastatic Solid Tumors, NSCLC, Melanoma Trial in United States (INBRX-105 - PDL1x41BB antibody, Pembrolizumab)
Recruiting
- Metastatic Solid Tumors
- +7 more
- INBRX-105 - PDL1x41BB antibody
- Pembrolizumab
-
Scottsdale, Arizona
- +12 more
Jan 26, 2023
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Houston (Fluorouracil, Leucovorin, Oxaliplatin)
Not yet recruiting
- Gastric Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
- Fluorouracil
- +4 more
-
Houston, Texas
- +3 more
Nov 13, 2022
Advanced Solid Tumor, Gynecologic Cancer, Breast Cancer Trial in United States (PY159 Single agent dose level 1, PY159 Single
Recruiting
- Advanced Solid Tumor
- +7 more
- PY159 Single agent dose level 1
- +17 more
-
San Francisco, California
- +11 more
Nov 3, 2022
Gastric Adenocarcinoma, Oligometastasis, Stage IV Esophageal Adenocarcinoma AJCC v7 Trial in Houston (drug, procedure,
Recruiting
- Gastric Adenocarcinoma
- +4 more
- Capecitabine
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 20, 2022
Advanced Solid Tumor, Metastatic Cancer, Refractory Cancer Trial in Huntersville, Houston, Webster (PT199, Anti-PD-1 mAb)
Recruiting
- Advanced Solid Tumor
- +18 more
- PT199
- Anti-PD-1 monoclonal antibody
-
Huntersville, North Carolina
- +2 more
Aug 10, 2022
Clinical Stage 0 Gastric Cancer AJCC v8, Clinical Stage 0 Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage I
Recruiting
- Clinical Stage 0 Gastric Cancer AJCC v8
- +27 more
- Fluorouracil
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jul 5, 2022
Small Cell Lung Cancer, Gastric Adenocarcinoma, Esophageal Adenocarcinoma Trial in United States (PDR001, LAG525)
Completed
- Small Cell Lung Cancer
- +7 more
- PDR001
- LAG525
-
San Francisco, California
- +19 more
May 4, 2022
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Peritoneal Carcinomatosis Trial in Houston (Cisplatin,
Active, not recruiting
- Gastric Adenocarcinoma
- +2 more
- Cisplatin
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Apr 12, 2022
Gastric Adenocarcinoma Trial in Houston (procedure, drug, other)
Not yet recruiting
- Gastric Adenocarcinoma
- Gastrectomy
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 3, 2022
Squamous Cell Carcinoma of the Head and Neck, Melanoma, Non Small Cell Lung Cancer Trial in Worldwide (SL-279252)
Recruiting
- Squamous Cell Carcinoma of the Head and Neck
- +12 more
-
Nashville, Tennessee
- +4 more
Feb 3, 2022
Solid Tumor, Triple-negative Breast Cancer, Gastric Adenocarcinoma Trial in Houston, Chuo-Ku (LY3435151, Pembrolizumab)
Terminated
- Solid Tumor
- +8 more
-
Houston, Texas
- +1 more
Aug 4, 2021
Clinical Stage I Gastric Cancer AJCC v8, Clinical Stage IIA Gastric Cancer AJCC v8, Clinical Stage III Gastric Cancer AJCC v8
Recruiting
- Clinical Stage I Gastric Cancer AJCC v8
- +15 more
- Capecitabine
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Aug 19, 2020
Assessment of What Patients and Healthcare Providers Value
Unknown status
- Gastric Adenocarcinoma
- +2 more
- Survey Administration
-
Houston, TexasM D Anderson Cancer Center
Jul 21, 2020
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Ramucirumab)
Completed
- Gastric Adenocarcinoma
- Gastroesophageal Junction Adenocarcinoma
-
Tucson, Arizona
- +44 more
Jun 26, 2020
Gastric Adenocarcinoma Trial in Worldwide (Andecaliximab, Placebo, Leucovorin)
NSCLC, Carcinoma, Renal Cell, Breast Tumors Trial in United States (SGN-2FF, pembrolizumab)
Terminated
- Carcinoma, Non-Small-Cell Lung
- +7 more
-
Birmingham, Alabama
- +10 more
Jul 17, 2019
Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma Trial in Georgia, United States
Unknown status
- Gastric Adenocarcinoma
- +2 more
-
Dallas, Texas
- +4 more
Nov 28, 2014
Gastroesophageal Adenocarcinoma, Gastric Adenocarcinoma Trial in Belgium, United Kingdom, United States (OSI-7904L)
Completed
- Gastroesophageal Adenocarcinoma
- Gastric Adenocarcinoma
-
Philadelphia, Pennsylvania
- +10 more
Feb 17, 2006